Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-08

Clinical Trial Update: Montmorency Cherry Supplementation, Sleep, and Inflammation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial from Michigan State University evaluated Montmorency cherry supplementation for chronic insomnia and inflammation; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montmorency cherry supplementation (Prunus cerasus extract (Montmorency cherry))

Snippet

Sponsor: Michigan State University | Conditions: Insomnia Chronic, Inflammation | Phase 1, Phase 2 | Status: COMPLETED